Denosumab in postmenopausal women with low bone mineral density

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2006-06, Vol.354 (22), p.2390
1. Verfasser: Rifkin, William D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 22
container_start_page 2390
container_title The New England journal of medicine
container_volume 354
creator Rifkin, William D
description
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16742010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16742010</sourcerecordid><originalsourceid>FETCH-pubmed_primary_167420103</originalsourceid><addsrcrecordid>eNpjYuA0NDU21jUxMTDjYOAqLs4yAAJDE0t2Bg5DM3MTIwNDA04Ge5fUvPzi0tzEJIXMPIWC_OKSXKBAQWJpcWKOQnk-kKNQnlmSoZCTX66QlJ-XqpCbmZdaBJRLSc0rziyp5GFgTUvMKU7lhdLcDHJuriHOHroFpUm5qSnxBUWZuYlFlfEwG40JKgAAtD82dg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Denosumab in postmenopausal women with low bone mineral density</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Rifkin, William D</creator><creatorcontrib>Rifkin, William D</creatorcontrib><identifier>EISSN: 1533-4406</identifier><identifier>PMID: 16742010</identifier><language>eng</language><publisher>United States</publisher><subject>Alendronate - therapeutic use ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized ; Bone Density - drug effects ; Bone Density Conservation Agents - therapeutic use ; Denosumab ; Ethics, Research ; Female ; Fractures, Bone ; Humans ; Osteoporosis, Postmenopausal - drug therapy ; Placebos - therapeutic use ; RANK Ligand ; Research Design ; Risk</subject><ispartof>The New England journal of medicine, 2006-06, Vol.354 (22), p.2390</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16742010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rifkin, William D</creatorcontrib><title>Denosumab in postmenopausal women with low bone mineral density</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><subject>Alendronate - therapeutic use</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Bone Density - drug effects</subject><subject>Bone Density Conservation Agents - therapeutic use</subject><subject>Denosumab</subject><subject>Ethics, Research</subject><subject>Female</subject><subject>Fractures, Bone</subject><subject>Humans</subject><subject>Osteoporosis, Postmenopausal - drug therapy</subject><subject>Placebos - therapeutic use</subject><subject>RANK Ligand</subject><subject>Research Design</subject><subject>Risk</subject><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpjYuA0NDU21jUxMTDjYOAqLs4yAAJDE0t2Bg5DM3MTIwNDA04Ge5fUvPzi0tzEJIXMPIWC_OKSXKBAQWJpcWKOQnk-kKNQnlmSoZCTX66QlJ-XqpCbmZdaBJRLSc0rziyp5GFgTUvMKU7lhdLcDHJuriHOHroFpUm5qSnxBUWZuYlFlfEwG40JKgAAtD82dg</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Rifkin, William D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20060601</creationdate><title>Denosumab in postmenopausal women with low bone mineral density</title><author>Rifkin, William D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_167420103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alendronate - therapeutic use</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Bone Density - drug effects</topic><topic>Bone Density Conservation Agents - therapeutic use</topic><topic>Denosumab</topic><topic>Ethics, Research</topic><topic>Female</topic><topic>Fractures, Bone</topic><topic>Humans</topic><topic>Osteoporosis, Postmenopausal - drug therapy</topic><topic>Placebos - therapeutic use</topic><topic>RANK Ligand</topic><topic>Research Design</topic><topic>Risk</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rifkin, William D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rifkin, William D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Denosumab in postmenopausal women with low bone mineral density</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>354</volume><issue>22</issue><spage>2390</spage><pages>2390-</pages><eissn>1533-4406</eissn><cop>United States</cop><pmid>16742010</pmid></addata></record>
fulltext fulltext
identifier EISSN: 1533-4406
ispartof The New England journal of medicine, 2006-06, Vol.354 (22), p.2390
issn 1533-4406
language eng
recordid cdi_pubmed_primary_16742010
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Alendronate - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Bone Density - drug effects
Bone Density Conservation Agents - therapeutic use
Denosumab
Ethics, Research
Female
Fractures, Bone
Humans
Osteoporosis, Postmenopausal - drug therapy
Placebos - therapeutic use
RANK Ligand
Research Design
Risk
title Denosumab in postmenopausal women with low bone mineral density
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A58%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Denosumab%20in%20postmenopausal%20women%20with%20low%20bone%20mineral%20density&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Rifkin,%20William%20D&rft.date=2006-06-01&rft.volume=354&rft.issue=22&rft.spage=2390&rft.pages=2390-&rft.eissn=1533-4406&rft_id=info:doi/&rft_dat=%3Cpubmed%3E16742010%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16742010&rfr_iscdi=true